BIOSINO BIO-TEC (08247) announced that Mr. Yang Peng, Dr. Gao Guangxia, Dr. Shen Sheng, Professor Shen Zuojun, and Dr. He Xin will not stand for re-election as they wish to devote more time to other commitments.

The Board has proposed the re-appointment of the remaining directors to the Ninth Board of Directors, pending shareholder approval at an extraordinary general meeting, with details as follows: re-appointment of the current executive director, Mr. Chen Zhengyong, as an executive director of the Ninth Board; re-appointment of the current executive director, Mr. Li Zhonghua, as an executive director of the Ninth Board; re-appointment of the current executive director, Mr. Chen Peng, as an executive director of the Ninth Board; re-appointment of the current independent non-executive director, Professor Shen Jiangang, as an independent non-executive director of the Ninth Board; and re-appointment of the current independent non-executive director, Mr. Fan Xiaoliang, as an independent non-executive director of the Ninth Board.

The following individuals have been nominated for appointment as directors of the Ninth Board of Directors, subject to shareholder approval at an extraordinary general meeting: appointment of Ms. Kang Rui as a non-executive director of the Ninth Board; and appointment of Professor Jin Tengchuan as an independent non-executive director of the Ninth Board.

Following the conclusion of the extraordinary general meeting, the composition of the Audit Committee, Nomination Committee, and Remuneration Committee under the Ninth Board of Directors will be as follows: Chairman of the Audit Committee: Mr. Fan Xiaoliang, Members: Professor Shen Jiangang and Professor Jin Tengchuan; Chairman of the Nomination Committee: Professor Jin Tengchuan, Members: Mr. Fan Xiaoliang and Professor Shen Jiangang; Chairman of the Remuneration Committee: Professor Shen Jiangang, Members: Mr. Fan Xiaoliang and Professor Jin Tengchuan.